Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-16

Maya Williams

High Impact

Assistant Professor

Faculty Researcher

30 h-index 139 pubs 3,325 cited

  • Humans
  • Animals
  • Female
  • Male
  • Adult
  • Culicidae
  • Arbovirus Infections
  • Hemagglutination Inhibition Tests
  • Insect Vectors
  • Middle Aged
  • Antibodies, Viral
  • Adolescent
  • Child
  • Dengue
  • Influenza, Human

Biography and Research Information

OverviewAI-generated summary

Maya Williams investigates the immunogenicity and safety of various vaccine candidates and therapeutic agents. Her work includes studies on adjuvanted psoralen-inactivated SARS-CoV-2 vaccines and SARS-CoV-2 spike protein DNA vaccines in mice, as well as enhanced immunogenicity of inactivated Dengue vaccines by novel polysaccharide-based adjuvants in mice. Williams also examines the safety and patient-reported outcomes of prolonged-release fampridine treatment in patients with multiple sclerosis.

Her research extends to veterinary medicine, with a publication on the prevalence of malignancy and factors affecting the outcome of cats undergoing splenectomy. Williams also contributes to educational research, exploring teacher perspectives on effective restorative practice implementation and conducting a scoping review on colorism in schools. Her scholarship metrics include an h-index of 30, 139 total publications, and 3,325 total citations, designating her as a highly cited researcher.

Metrics

  • h-index: 30
  • Publications: 139
  • Citations: 3,325

Selected Publications

  • Consultant perception of the feasibility and effectiveness of infant and early childhood mental health consultation services provided virtually to early care and education (2025)
    Infant Mental Health Journal DOI OpenAlex
  • A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025)
    medRxiv 3 citations DOI OpenAlex
  • A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023)
    Journal of Clinical Oncology 2 citations DOI OpenAlex
  • HPV-associated Vulvar Intraepithelial Carcinoma With Sebaceous Differentiation: Report of 2 Cases (2022)
    International Journal of Gynecological Pathology 4 citations DOI OpenAlex
  • Comparison of Chloroprocaine Versus Lidocaine With Epinephrine, Sodium Bicarbonate, and Fentanyl for Epidural Extension Anesthesia in Elective Cesarean Delivery: A Randomized, Triple-blind, Noninferiority Study (2022)
    Obstetric Anesthesia Digest 1 citation DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

10 Collaborators 7 Institutions 2 Countries

Top Collaborators

View profile →

Similar Researchers

Based on overlapping research topics